SECOND OPINIONS, STRONGER OUTCOMES: A VIRTUAL GUIDE TO ERECTILE & EJACULATORY HEALTH

Introduction

If you’re a man dealing with sexual dysfunction—whether it’s trouble getting or keeping an erection or issues with ejaculation—you might be feeling confused, frustrated, or even hopeless. It’s common to wonder: Is the treatment my doctor gave me the only option? Is there something else going on with my health? These concerns are completely understandable. Sexual dysfunction, including erectile dysfunction (ED) and ejaculation problems such as premature, delayed, absent, or retrograde ejaculation, can deeply affect confidence and relationships. The good news is that you don’t have to settle for uncertainty. Seeking a second opinion for male sexual health can offer a fresh perspective on your condition and ensure you’re aware of all the options available for evaluation and treatment. This isn’t about offending your current clinician or “doctor shopping”—it’s about you getting the best possible care and peace of mind.

In this blog, we explore why a second opinion—especially a virtual second opinion for male sexual health—can be so valuable for men with ED or ejaculatory issues. We’ll cover what these conditions are, why they happen, how they affect both the individual and the couple, when to consider a second opinion, how virtual consultations work, what to look for in a specialist, what a thorough second-opinion evaluation includes, and the range of evidence-based options you can consider.

You’re Not Alone: Understanding Sexual Dysfunction (Without the Shame)

Sexual dysfunction doesn’t make headlines, but it touches millions of lives. Erectile dysfunction becomes more common with age, yet it can occur at any age and is often underdiagnosed because many men hesitate to bring it up. Ejaculatory disorders—most commonly premature ejaculation (PE), but also delayed ejaculation, anejaculation (no ejaculation), and retrograde ejaculation—are similarly common and, like ED, are frequently underreported due to embarrassment.

Why normalize this? Because silence makes problems feel insurmountable, understanding that these conditions are common, multifactorial, and treatable can lift a heavy psychological burden. Sexual function reflects a blend of vascular, neurologic, endocrine, and psychological pathways. That means both physical and emotional contributors typically matter. Diabetes, hypertension, high cholesterol, obesity, smoking, certain medications, pelvic surgery, sleep disorders, depression, anxiety, and relationship stress can all play roles. For ejaculatory concerns, endocrine issues (thyroid), prostatitis, pelvic floor dysfunction, and medication effects (especially SSRIs) often contribute; for PE, neurobiologic disposition and performance anxiety may interact. A good second-opinion workup assumes complexity rather than oversimplifying.

Importantly, sexual symptoms sometimes flag broader health risks. ED is associated with cardiovascular disease—in many men, it precedes clinical heart disease by years. That’s not to frighten you; it’s to empower you. A second opinion that connects the dots between sexual symptoms and cardiometabolic health can save more than your sex life.

Why a Second Opinion Helps (Even When You Already Have a Diagnosis)

A second opinion isn’t a vote of no confidence in your current doctor. It’s an information- and options-expanding step. Here’s why it’s often worth it:

Clarity about Cause(s). ED and ejaculatory problems are usually multifactorial. A fresh review can spot missed contributors: medication side effects, untreated testosterone deficiency, thyroid dysfunction, sleep apnea, LUTS (lower urinary tract symptoms), pelvic floor dysfunction, or anxiety/relationship factors. For ejaculatory issues, unrecognized prostatitis, endocrine factors, or coexisting ED can perpetuate symptoms. Getting the etiology right guides the plan.
A broader playbook. If pills didn’t help—or helped partially—there’s a robust menu of other options: dosing tweaks, trying a different PDE5 inhibitor, daily low-dose tadalafil, combination strategies (e.g., PDE5 inhibitor + vacuum device), intraurethral alprostadil, intracavernosal injections, pelvic floor therapy, psychosexual therapy, and, for the right candidate, penile prosthesis surgery. For PE, guideline-directed options include topical anesthetics, SSRIs/clomipramine (daily or on demand, where available), behavioral techniques, and couples-focused therapy. A second-opinion specialist lays these out dispassionately, helping you choose what fits your goals and risk tolerance.
Perspective and realistic expectations. Honest talk about what “success” looks like—improved function, reduced distress, regained intimacy—reduces pressure and improves outcomes. For example, partial pharmacologic improvement plus anxiety reduction and couple-based strategies may produce a better overallresult than a “stronger pill” alone.
Safety and whole-person health. A thoughtful second opinion screens for contraindications (e.g., nitrates and PDE5i), drug interactions, and cardiometabolic risk. When indicated, it prompts heart-healthy changes that often improve erections and longevity.
Major decisions deserve confirmation. Considering a prosthesis, reconstructive surgery, or an invasive ejaculatory procedure? Independent counsel lets you weigh durability, satisfaction, and risks—without sales pressure.
Reassurance. Even when the plan doesn’t change, two aligned expert views calm worries and strengthen adherence.

The Virtual Advantage: How a Virtual Second Opinion for Male Sexual Health Works

Technology has made expert care more accessible. A virtual second opinion can deliver specialty insight without travel, days off work, or crowded waiting rooms. Here’s what to expect:

Pre-visit intake. You’ll complete questionnaires and upload prior records: clinic notes, labs, imaging, prior treatments and responses. If fertility intersects with sexual function, include semen analyses and hormone panels.
Private, partner-inclusive visit. Meet via secure, HIPAA-compliant video from a private space. Partners can easily join from another location—often helpful for context and support.
Strengths. Convenience, comfort, access to national experts, partner participation, and often a written summaryof impressions and recommendations you can share with local clinicians.
Limitations. Physical exam is limited. A high-quality teleconsult will identify any gaps and recommend targeted in-person exam or tests (genital exam, penile Doppler, prostate evaluation) when needed.
What virtual isn’t. Quick-prescription “ED websites” have a role, but a true second opinion is comprehensive and options-neutral, not a one-size-fits-all product funnel.

Many academic centers and men’s health practices provide virtual consults and formal second-opinion programs. Choose those that emphasize individualized assessment, evidence-based recommendations, and collaboration with your local care team.

Choosing the Right Consultant (Even If They Won’t Be the Treating Doctor)

You’re seeking advice, not necessarily a new primary clinician. Look for:

Subspecialized expertise. Urologists with fellowship training in andrology/sexual medicine or reproductive urology; clinicians active in SMSNA/ISSM and have written in peer-reviewed journals; those who routinely manage ED, Peyronie’s, ejaculatory disorders, hypogonadism, and male infertility.
Objectivity. Beware of one-trick practices that push a single procedure or device. A good consultant covers all appropriate options, including those they don’t sell or perform, and refers to centers of excellence when that better serves you.
Guideline literacy. Alignment with AUA/SMSNA and ISSM guidance for ED and PE; nuanced understanding of where evidence is strong vs evolving (e.g., shockwave therapy, PRP, stem cells).
Communication style. Compassionate, nonjudgmental, inclusive of your partner, and unhurried. Sexual health requires trust and candor.
Fertility lens when relevant. If conception matters, reproductive urologists bridge sexual function and fertility, coordinating semen testing, endocrine evaluation, and ejaculatory physiology.

Preparing for Your Second Opinion: Make It Count

Gather records. Prior notes, lab results (testosterone with SHBG or free T, prolactin, TSH, A1c, lipids), imaging (penile Doppler), sleep studies, semen analyses, medication list (including supplements), and a timeline of symptoms and treatments tried (dose, duration, response, side effects).
Set goals. What outcomes matter most—erection firmness, duration to ejaculation, reduced anxiety, spontaneity, fertility, minimizing side effects? Clear goals shape recommendations.
List questions. Etiology, safety, alternatives, prognosis, next steps if first-line fails, partner involvement, insurance coverage, and logistics (e.g., training for injection therapy).
Invite your partner. A couple-centered visit improves understanding, reduces blame, and supports behavior change.
Expect candor. The consultant should synthesize your case and deliver a roadmap—tests to obtain, first- and second-line options, escalation paths, and when to loop in other specialists (cardiology, endocrinology, pelvic PT, sex therapy).

The Evaluation: What a Thorough Second Opinion Looks Like

History. Symptom onset, progression, situational vs generalized dysfunction, morning/nocturnal erections, masturbation vs partnered function, orgasm quality, penile deformity/pain, lower urinary tract symptoms, pelvic pain, libido, mood, relationship context, prior surgeries (pelvic, prostate, spine), neurologic history, medications/substances (antihypertensives, SSRIs, 5α-reductase inhibitors, opioids, alcohol, nicotine), sleep quality.

Physical exam (in-person when needed). Genital exam for plaques (Peyronie’s), curvature, phimosis, testis volume/consistency, varicocele, secondary sex characteristics; peripheral pulses and neuropathy screen; prostate exam when indicated (painful ejaculation, LUTS).

Laboratory tests. Morning total testosterone (ideally repeated), free T or calculated free T when SHBG abnormal, LH/FSH when hypogonadism suspected, prolactin (hyperprolactinemia can reduce libido and orgasm), TSH, fasting glucose/A1c, lipids; consider estradiol in obesity/gynecomastia; CRP rarely.

Functional testing. Nocturnal penile tumescence/rigiScan for psychogenic vs organic differentiation (although few Urologists specializing in male sexual function have this equipment); penile duplex Doppler with pharmacologic erection to evaluate arterial inflow and veno-occlusive function; uroflow/post-void residual if LUTS present; semen analysis (if fertility goals).

Validated questionnaires. IIEF for ED, PEDT for PE, SHIM, and distress/relationship measures as appropriate.

Risk assessment. Cardiovascular risk stratification (per Princeton Consensus) before sexual activity and PDE5i use; sleep apnea screening; depression/anxiety screening.

The point isn’t to collect every test—it’s to target the testing to your presentation so that treatment is rational and efficient.

Evidence‑Based Options: Building a Personalized Plan

Foundational Moves (Often Overlooked, Highly Impactful)

Lifestyle optimization. Weight loss, aerobic and resistance exercise, smoking cessation, alcohol moderation, better sleep—these improve endothelial function, testosterone, and mood. Even modest changes can enhance erectile rigidity and ejaculatory control while improving overall health.
Medication reconciliation. Review drugs that impair erections or ejaculation (certain antihypertensives, SSRIs/SNRIs, antipsychotics, finasteride, opioids). Where possible, substitute agents with fewer sexual side effects or adjust doses/timing.
Couple-centered counseling. Normalize expectations, reduce performance pressure, and improve communication. Sexual function is relational; partner understanding and participation matter.

Erectile Dysfunction: Stepwise, Not One-Size-Fits-All

Oral PDE5 inhibitors. Sildenafil, tadalafil, vardenafil, avanafil remain first-line for most men without contraindications. Key nuances: correct dosing (sildenafil 50–100 mg; tadalafil 10–20 mg on demand or 2.5–5 mg daily), timing (on empty stomach for sildenafil/vardenafil), sexual stimulation required, and adequate trial (several attempts). Switching molecules or adopting daily tadalafil can restore spontaneity.
Adjuncts and combinations. Vacuum erection device (VED) either as monotherapy or combined with PDE5i; intraurethral alprostadil (MUSE) for those avoiding injections; optimizing testosterone if clearly low (caution with fertility).
Intracavernosal injection (ICI) therapy. Alprostadil or combination agents (e.g., Trimix) produce robust erections independent of neural input. Proper dosing and training minimize risks (priapism, fibrosis). Many couples find ICI reliable and satisfying once technique is learned.
Penile prosthesis. For refractory ED or when a definitive solution is preferred. Modern inflatable devices offer high satisfaction for patients and partners, rapid reliability, and long-term durability, at the cost of surgery and loss of natural erectile tissue function. A second opinion is ideal before this step to ensure readiness and alignment of expectations.
Emerging/adjunctive therapies. Low‑intensity shockwave therapy (Li‑ESWT) shows promise for vasculogenic ED in trials but remains variably adopted; PRP and stem cells are investigational. A prudent consultant will outline current evidence and costs without overselling.

Ejaculatory Disorders: Matching Strategy to Mechanism

Premature Ejaculation (PE).

Education & behavioral techniques. Start–stop, squeeze technique, sensate focus exercises, mindfulness, and pelvic floor training can extend latency and reduce anxiety.
Topical anesthetics. Lidocaine/prilocaine creams or sprays reduce hypersensitivity. Proper application (with condom or wiped off before penetration) minimizes partner numbness.
Pharmacotherapy. SSRIs (paroxetine, sertraline, fluoxetine) or clomipramine—daily or, in some regimens, on-demand—are guideline‑endorsed first‑line options; dapoxetine (short‑acting SSRI) is on‑demand where available. Tramadol is a second‑line option when others fail, with careful risk assessment.
Treat comorbidities. Address ED, prostatitis, thyroid dysfunction, or anxiety disorders that perpetuate PE.

Delayed Ejaculation/Anejaculation.

Medication review and adjustment. Antidepressants and antipsychotics commonly delay orgasm; targeted changes can help. Correct hypogonadism when present.
Stimulation strategies. Vibratory stimulation devices, novel arousal cues, and extended foreplay can assist. Sex therapy addresses cognitive/relational barriers.
Fertility-oriented options. For retrograde ejaculation, alpha‑agonists (e.g., pseudoephedrine) occasionally help; sperm retrieval from post‑ejaculatory urine or vibratory/electroejaculation at specialized centers enable assisted reproduction.

Psychosexual Therapy and Pelvic Floor Physical Therapy

These are not “last resorts”—they’re core modalities for many men. Sex therapy helps dismantle avoidance cycles, catastrophic thinking, and mismatched expectations. Pelvic floor PT addresses hypertonicity, coordination, and endurance in ways that pills cannot. When layered with medical therapy, outcomes often improve synergistically.

Setting Expectations: What “Better” Looks Like

Your consultant should translate evidence into personalized probabilities rather than promises. Examples:

“Daily tadalafil plus weight loss is likely to improve erection quality and spontaneity; if you’re still not satisfied after 8–12 weeks, we can add VED or demonstrate ICI.”
“Topical anesthetic plus an SSRI often increases intravaginal ejaculatory latency several‑fold; we’ll titrate to balance control with side effects.”
“If performance anxiety is central, therapy and low‑dose PDE5i together can break the negative feedback loop.”
“If your vascular ED is severe on Doppler, pills may be insufficient—ICI or prosthesis are the most reliable next steps.”

Clarity reduces the pressure to “perform” and helps couples reframe sex as exploration rather than a pass/fail test. Paradoxically, this mindset often enhances function.

Safety First: Cardiometabolic Health, Sleep, and Mental Well‑Being

Cardiac risk. Determine if it’s safe to resume sexual activity and use ED meds; manage hypertension, dyslipidemia, prediabetes/diabetes aggressively. ED can be an early atherosclerosis clue—addressing it improves outcomes beyond the bedroom.
Sleep. Treat sleep apnea and circadian disruption; quality sleep supports testosterone and endothelial health.
Mood & substance use. Screen for depression/anxiety and hazardous alcohol or cannabis use that can impair sexual response; treat or modify as needed.
Prostate & pelvic health. Evaluate LUTS and prostatitis when symptoms suggest; treat to reduce painful ejaculation or ejaculatory dysfunction.

How Partners and Families Can Help (And Why Their Support Matters)

Sexual dysfunction is a shared challenge for couples. Partners often misinterpret ED (“I’m not attractive to him”) or PE (“He doesn’t care about my pleasure”), compounding distress. Involving partners in the second opinion fosters empathy: ED is frequently vascular/neurologic, PE is highly treatable, and both are not character flaws. Partners can help by:

Joining the visit (virtually or in person) and asking questions
Avoiding blame or pressure; affirming desire and patience
Practicing behavioral techniques together; celebrating small wins
Supporting lifestyle changes (e.g., exercise, sleep hygiene)

For family members offering support to a loved one (e.g., adult children encouraging care), emphasize that sexual symptoms are medical and common—and that help is available.

Cost, Coverage, and Practicalities

Insurance. Most evaluations and first‑line ED/PE treatments are covered; some therapies (certain devices, Li‑ESWT, PRP) may be out‑of‑pocket. Ask about generics and patient assistance.
Training and follow‑through. If trying ICI, expect an in‑office teaching visit. If starting therapy or pelvic PT, ask for providers with sexual‑health expertise.
Written plan. Request a summary with stepwise options and triggers to escalate care; share it with your primary clinicians.
Follow‑up. Reassess at 6–12 weeks; adjust doses, add or subtract modalities, and revisit goals.

Red Flags and Marketing Hype: A Brief Reality Check

Miracle cures. Be skeptical of guaranteed fixes, pricey “packages,” and aggressive upsells. Evidence‑based care acknowledges uncertainty and offers options, not absolutes.
Overpromising new tech. Li‑ESWT has encouraging data for select men; PRP/stem cells remain investigational. A good consultant clearly marks the evidence line.
One‑tool clinics. If every man “needs” the same device or procedure, seek a broader perspective.

Putting It All Together: A Sample Roadmap

Case A (ED + cardiometabolic risk). 58‑year‑old with progressive ED, hypertension, elevated A1c, central obesity. Plan: cardiac risk stratification; A1c and lipids optimization; daily tadalafil + lifestyle plan; add VED as needed; reassess at 12 weeks. If inadequate rigidity, trial ICI; discuss prosthesis if refractory.

Case B (lifelong PE, high distress). 32‑year‑old with IELT ~60–90 seconds, high anxiety. Plan: education, start–stop technique, topical anesthetic, on‑demand SSRI where appropriate; couple‑based therapy; screen and treat comorbid ED if present; reassess in 8 weeks and titrate.

Case C (post‑prostatectomy ED). 66‑year‑old, 18 months post‑RP with minimal PDE5i response. Plan: VED for rehabilitation + ICI training; explore prosthesis with shared decision‑making; validate grief and reframe intimacy during rehabilitation.

Case D (delayed ejaculation on SSRI). 45‑year‑old with depression well‑controlled on SSRI, new DE. Plan: coordinate with psychiatry for switch to bupropion or dose/timing changes; adjunct PDE5i if arousal low; sex therapy focusing on arousal cues and partner strategies; reassess in 6–8 weeks.

The Payoff: Confidence, Connection, and Control

A second opinion—especially a virtual second opinion for male sexual health—isn’t about starting over; it’s about widening the path forward. The payoff is clarity about causes, a tailored set of options, and realistic expectations. For many men and couples, that combination rekindles confidence, restores intimacy, and embeds heart‑healthy habits with benefits far beyond the bedroom. Even when the journey involves trial and error, you’re no longer navigating in the dark.

You’re not alone. With evidence‑based guidance, partner support, and a stepwise plan, most men regain satisfying sexual function. And if the best next step is a referral to a different clinician or center, a truly unbiased consultant will point you there. That’s what patient‑centered care looks like.

References

Shamloul R, Ghanem H. Erectile dysfunction. Lancet. 2013;381(9861):153-165.
Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. J Urol. 2018;200(3):633-641.
Levine LA, Althof SE, Chen TF, et al. American Urological Association/Sexual Medicine Society of North America Guideline on the Management of Premature Ejaculation (2022). J Urol. 2022;208(4):745-754.
Montorsi F, Adaikan G, Becher E, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2010;7(11):3572-3588.
Hatzimouratidis K, Giuliano F, Moncada I, et al. European Association of Urology Guidelines on Male Sexual Dysfunction. Eur Urol. 2016;70(2):336-353.
Miner M, Seftel AD, Nehra A, Ganz P. Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes. Am Heart J. 2012;164(1):21-28.
Montorsi P, Ravagnani PM, Galli S, et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol. 2005;96(12B):19M-23M.
Kloner RA, Jarow JP, Moon TE, et al. Cardiovascular safety of sildenafil citrate (Viagra). Am J Cardiol.1999;83(5A):35C-44C.
Goldstein I, Young JM, Fischer J, Bangerter K, Segerson T, Taylor T. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction: a randomized, double-blind, placebo-controlled trial. J Urol.2003;169(5):1463-1469.
Porst H, Rosen RC, Padma-Nathan H, et al. The Premature Ejaculation Prevalence and Attitudes (PEPA) survey. Eur Urol. 2007;51(3):816-823.
McMahon CG. Premature ejaculation: state of the art. J Urol. 2019;202(4):737-748.
Waldinger MD. Lifelong premature ejaculation: definition, operational criteria, and pathogenesis. World J Urol.2005;23(2):97-102.
Kingsberg SA, Althof SE. Patient–provider communication about sexual concerns. J Sex Med. 2014;11(2):543-557.
Li H, Gao T, Wang R. The role of the sexual partner in managing erectile dysfunction. Nat Rev Urol.2016;13(3):168-176.
Hackett G, Heald AH, Sinclair A, Ramachandran S, Jones PW, Strange RC. Serum testosterone and erectile dysfunction in diabetic men. Int J Clin Pract. 2008;62(3):375-382.
Corona G, Mannucci E, Lotti F, et al. Hypogonadism, ED, and metabolic syndrome in men. J Sex Med.2009;6(9):2511-2519.
Khera M. Androgen replacement therapy and cardiovascular risks. Nat Rev Cardiol. 2014;11(1):26-40.
Yuan J, Zhang R, Yang Z, et al. Comparative effectiveness of oral PDE5 inhibitors for ED: a systematic review and network meta-analysis. Eur Urol. 2013;63(5):902-912.
Capogrosso P, Colicchia M, Ventimiglia E, et al. One patient out of four with newly diagnosed ED is a young man. J Sex Med. 2013;10(7):1833-1841.
Abdel-Rahman I, et al. Long-term penile prosthesis couple’s satisfaction: a systematic review and meta-analysis. Andrology. 2022;10(4):806-814.
Pastuszak AW, Wenker EP, Cold CJ, et al. Intracavernosal injection therapy: patient satisfaction and predictors of continued use. J Sex Med. 2012;9(11):2817-2823.
Naessens JM, et al. Changes in diagnosis after referral to a tertiary center for second opinion. J Eval Clin Pract.2017;23(6):1305-1310.
Burger PM, Westerink J, Vrijsen BEL. Outcomes of second opinions in internal medicine. PLoS One.2020;15(8):e0236048.
Saffati G, et al. Satisfaction with telemedicine in sexual medicine: a large cohort analysis. Sex Med.2023;11(6):qfad060.
RigiScan: Carani C, et al. Nocturnal penile tumescence monitoring in ED. J Endocrinol Invest. 2004;27(7):620-628.
Mulhall JP, Burnett AL, Wang R, et al. AUA white paper on benign prostatic hyperplasia and sexual dysfunction. J Urol. 2018;200(2):327-334.
Abdel-Hamid IA, et al. Topical anesthetics in premature ejaculation: evidence synthesis. J Sex Med.2013;10(10):2512-2527.
Waldinger MD, Schweitzer DH. The use of SSRIs in premature ejaculation. Int J Impot Res. 2008;20(1):9-14.
Taylor MJ, Rudkin L, Bullemor-Day P, Lubin J, Chukwujekwu C, Hawton K. Strategies for managing sexual dysfunction induced by serotonergic antidepressants. Cochrane Database Syst Rev. 2013;(5):CD003382.
Lu Z, Lin G, Reed-Maldonado A, Wang C, Lee YC, Lue TF. Low-intensity extracorporeal shock wave therapy for ED: a systematic review and meta-analysis. Int J Impot Res. 2017;29(4):195-201.
Althof SE. Psychological treatments for sexual dysfunction. Urol Clin North Am. 2011;38(2):167-179.
Hennekens CH, Dyken ML, Fuster V. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC). Arch Intern Med. 1997;157(21):2413-2446. (Cardiovascular risk modification framework.)
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment. Urology. 1997;49(6):822-830.
Heiman JR, Meston CM. Empirically validated treatments for sexual dysfunction. Annu Rev Sex Res.1997;8:148-194.
Basson R. The female sexual response: relevance to male dysfunction as a couple’s issue. J Sex Marital Ther.2000;26(1):51-65.
Montague DK, Jarow JP, Broderick GA, et al. AUA guideline on the management of erectile dysfunction (historic). J Urol. 2005;174(1):230-239.
Hsieh TC, Pastuszak AW, Hotaling JM. Varicocele and male sexual function. Sex Med Rev. 2017;5(2):133-140.
Ko YH, et al. Pelvic floor muscle training in men with sexual dysfunction. Int Neurourol J. 2019;23(3):217-225.
DeLay KJ, Mulhall JP. Outcomes of vacuum erection device for erectile rehabilitation. Sex Med Rev.2016;4(2):110-117.
Hackett G, Kirby M, Wylie K, et al. British Society for Sexual Medicine Guidelines on ED in men with comorbidities. J Sex Med. 2018;15(9):1214-1235.